| 臺大學術典藏 |
2021-10-14T02:45:25Z |
Subsequent risk of acute urinary retention and androgen deprivation therapy in patients with prostate cancer: A population-based retrospective cohort study
|
Yang T.-K.; Wu C.-C.; Chang C.-H.; Muo C.-H.; CHAO-YUAN HUANG; Chung C.-J. |
| 臺大學術典藏 |
2021-10-14T02:45:25Z |
Associations between Peripheral Thromboembolic Vascular Disease and Androgen Deprivation Therapy in Asian Prostate Cancer Patients
|
Lu Y.-C.; CHAO-YUAN HUANG; Yeh H.-M.; Hong J.-H.; Chang C.-H.; Muo C.-H.; Chung S.-D.; Yang T.-K.; Jaw F.-S.; Chung C.-J. |
| 臺大學術典藏 |
2021-10-14T02:45:24Z |
Different androgen deprivation therapies might have a differential impact on cognition - An analysis from a population-based study using time-dependent exposure model
|
Hong J.-H.; CHAO-YUAN HUANG; Chang C.-H.; Muo C.-H.; Jaw F.-S.; Lu Y.-C.; Chung C.-J. |
| 臺大學術典藏 |
2021-10-14T02:45:22Z |
Polymorphism of nucleotide binding domain-like receptor protein 3 (NLRP3) increases susceptibility of total urinary arsenic to renal cell carcinoma
|
Chung C.-J.; Bao B.-Y.; Lin Y.-C.; Huang Y.-L.; Shiue H.-S.; Ao P.-L.; Pu Y.-S.; CHAO-YUAN HUANG; Hsueh Y.-M. |
| 臺大學術典藏 |
2021-10-14T02:45:21Z |
Effect of plasma selenium, red blood cell cadmium, total urinary arsenic levels, and eGFR on renal cell carcinoma
|
Hsueh Y.-M.; Lin Y.-C.; Huang Y.-L.; Shiue H.-S.; Pu Y.-S.; CHAO-YUAN HUANG; Chung C.-J. |
| 臺大學術典藏 |
2021-08-20T04:14:09Z |
Increased risk of end-stage renal disease in patients with renal cell carcinoma: A 12-year nationwide follow-up study
|
Hung P.-H.; Tsai H.-B.; KUAN-YU HUNG; Muo C.-H.; Chung M.-C.; Chang C.-H.; Chung C.-J. |
| 臺大學術典藏 |
2021-08-20T04:14:01Z |
Patients with urothelial carcinoma have poor renal outcome regardless of whether they receive nephrouretectomy
|
Hung P.-H.; Tsai H.-B.; KUAN-YU HUNG; Muo C.-H.; Chung M.-C.; Chang C.-H.; Chung C.-J. |
| 臺大學術典藏 |
2021-08-20T04:13:52Z |
Clinically diagnosed urticaria and risk of systemic lupus erythematosus in children: A nationwide population-based case-control study
|
Lin C.-H.; Hung P.-H.; Hu H.-Y.; Chung C.-J.; Chen T.-H.; KUAN-YU HUNG |
| 臺大學術典藏 |
2021-08-20T04:13:48Z |
Clinical burden of autosomal dominant polycystic kidney disease
|
Hung P.-H.; Lin C.-H.; KUAN-YU HUNG; Muo C.-H.; Chung M.-C.; Chang C.-H.; Chung C.-J. |
| 臺大學術典藏 |
2021-02-04T02:30:25Z |
Different androgen deprivation therapies might have a differential impact on cognition - An analysis from a population-based study using time-dependent exposure model
|
Hong, J.-H.;Huang, C.-Y.;Chang, C.-H.;Muo, C.-H.;Jaw, F.-S.;Lu, Y.-C.;Chung, C.-J.Fu-Shan Jaw; Hong, J.-H.; Huang, C.-Y.; Chang, C.-H.; Muo, C.-H.; Jaw, F.-S.; Lu, Y.-C.; Chung, C.-J.; FU-SHAN JAW |
| 臺大學術典藏 |
2021-02-02T00:46:58Z |
Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure
|
Yeong-Shiau Pu;Yang S.-M.;Huang Y.-K.;Chung C.-J.;Huang S.K.;Chiu A.W.-H.;Yang M.-H.;Chen C.-J.;Hsueh Y.-M.; YEONG-SHIAU PU; Yang S.-M.; Huang Y.-K.; Chung C.-J.; Huang S.K.; Chiu A.W.-H.; Yang M.-H.; Chen C.-J.; Hsueh Y.-M. |
| 臺大學術典藏 |
2021-02-02T00:46:55Z |
Urinary 8-hydroxydeoxyguanosine and urothelial carcinoma risk in low arsenic exposure area
|
Chung C.-J.; Huang C.-J.; YEONG-SHIAU PU; Su C.-T.; Huang Y.-K.; Chen Y.-T.; Hsueh Y.-M. |
| 臺大學術典藏 |
2021-02-02T00:46:53Z |
Plasma folate level, urinary arsenic methylation profiles, and urothelial carcinoma susceptibility
|
Huang Y.-K.; YEONG-SHIAU PU; Chung C.-J.; Shiue H.-S.; Yang M.-H.; Chen C.-J.; Hsueh Y.-M. |
| 臺大學術典藏 |
2021-02-02T00:46:52Z |
Arsenic methylation capability, heme oxygenase-1 and NADPH quinone oxidoreductase-1 genetic polymorphisms and the stage and grade of urothelial carcinomas
|
Huang S.K.; Chiu A.W.-H.; YEONG-SHIAU PU; Huang Y.-K.; Chung C.-J.; Tsai H.-J.; Yang M.-H.; Chen C.-J.; Hsueh Y.-M. |
| 臺大學術典藏 |
2021-02-02T00:46:51Z |
Correlation between the urine profile of 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone metabolites and N7-methylguanine in urothelial carcinoma patients
|
Lee H.-L.; Hsueh Y.-M.; Chung C.-J.; YEONG-SHIAU PU; Chang L.W.; Hsieh D.P.H.; Liou S.-H.; Lin P. |
| 臺大學術典藏 |
2021-02-02T00:46:51Z |
Polymorphisms in cell cycle regulatory genes, urinary arsenic profile and urothelial carcinoma
|
Chung C.-J.; Huang C.-J.; YEONG-SHIAU PU; Su C.-T.; Huang Y.-K.; Chen Y.-T.; Hsueh Y.-M. |
| 臺大學術典藏 |
2021-02-02T00:46:49Z |
Arsenic methylation capability, myeloperoxidase and sulfotransferase genetic polymorphisms, and the stage and grade of urothelial carcinoma
|
Huang S.K.; Chiu A.W.-H.; YEONG-SHIAU PU; Huang Y.-K.; Chung C.-J.; Tsai H.-J.; Yang M.-H.; Chen C.-J.; Hsueh Y.-M. |
| 臺大學術典藏 |
2021-02-02T00:46:49Z |
Correlation between the urine profile of 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone metabolites and n7-methylguanine in urothelial carcinoma patients (Cancer Epidemiology Biomarkers and Prevention (2008) 17, (3390-3395))
|
Lee H.-L.; Hsueh Y.-M.; Chung C.-J.; YEONG-SHIAU PU; Chang L.W.; Hsientang Hsieh D.P.; Liou S.-H.; Lin P. |
| 臺大學術典藏 |
2021-02-02T00:46:43Z |
Polymorphisms in one-carbon metabolism pathway genes, urinary arsenic profile, and urothelial carcinoma
|
Chung C.-J.;Yeong-Shiau Pu;Su C.-T.;Chen H.-W.;Huang Y.-K.;Shiue H.-S.;Hsueh Y.-M.; Chung C.-J.; YEONG-SHIAU PU; Su C.-T.; Chen H.-W.; Huang Y.-K.; Shiue H.-S.; Hsueh Y.-M. |
| 臺大學術典藏 |
2021-02-02T00:46:43Z |
Gene polymorphisms of glutathione S-transferase omega 1 and 2, urinary arsenic methylation profile and urothelial carcinoma
|
Chung C.-J.; YEONG-SHIAU PU; Su C.-T.; Huang C.-Y.; Hsueh Y.-M. |
| 臺大學術典藏 |
2021-02-02T00:46:41Z |
Effect of urinary total arsenic level and estimated glomerular filtration rate on the risk of renal cell carcinoma in a low arsenic exposure area
|
Huang C.-Y. ;Chu J.-S. ;Yeong-Shiau Pu ;Yang H.-Y. ;Wu C.-C. ;Chung C.-J. ;Hsueh Y.-M.; Huang C.-Y.; Chu J.-S.; YEONG-SHIAU PU; Yang H.-Y.; Wu C.-C.; Chung C.-J.; Hsueh Y.-M. |
| 臺大學術典藏 |
2021-02-02T00:46:41Z |
Low ratio of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol-glucuronides (NNAL-Gluc)/free NNAL increases urothelial carcinoma risk
|
Chung C.-J.; Lee H.-L.; Yang H.-Y.; Lin P.; YEONG-SHIAU PU; Shiue H.-S.; Su C.-T.; Hsueh Y.-M. |
| 臺大學術典藏 |
2021-02-02T00:46:41Z |
Protective effects of plasma alpha-tocopherols on the risk of inorganic arsenic-related urothelial carcinoma
|
Chung C.-J.; YEONG-SHIAU PU; Chen Y.-T.; Su C.-T.; Wu C.-C.; Shiue H.-S.; Huang C.-Y.; Hsueh Y.-M. |
| 臺大學術典藏 |
2021-02-02T00:46:39Z |
The polymorphisms of P53 codon 72 and MDM2 SNP309 and renal cell carcinoma risk in a low arsenic exposure area
|
Huang C.-Y.;Su C.-T.;Chu J.-S.;Huang S.-P.;Yeong-Shiau Pu;Yang H.-Y.;Chung C.-J.;Wu C.-C.;Hsueh Y.-M.; Huang C.-Y.; Su C.-T.; Chu J.-S.; Huang S.-P.; YEONG-SHIAU PU; Yang H.-Y.; Chung C.-J.; Wu C.-C.; Hsueh Y.-M. |
| 臺大學術典藏 |
2021-02-02T00:46:35Z |
Joint effect of arsenic methylation profile and NNK metabolites on urothelial carcinoma
|
Wu C.-C.; Su C.-T.; Lee H.-L.; Chung C.-J.; Huang C.-Y.; YEONG-SHIAU PU; Lin P.; Hsueh Y.-M. |
